Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2018 Catalysts – Markets Insider
|
Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2018 Catalysts
Markets Insider Synlogic (Nasdaq: SYBX), a clinical-stage company applying synthetic biology to probiotics to develop novel living medicines, today provided an overview of recent progress and outlined key objectives and anticipated milestones for 2018. "For Synlogic … |
